Figure 13.

A, The relative expression of MBD2a, MBD2c in fetal liver, adult liver, HCC, and adjacent noncancerous liver tissues. ∗∗∗P < .001 by the Student t test. B-C, The Kaplan-Meier analyses of the correlations between MBD2a (B), MBD2c (C) level and overall survival of n = 100 patients with HCC. The median MBD2a or MBD2c level was used as the cutoff. D, The multivariate analysis for MBD2a and MBD2c in patients with HCC. E, The correlation analysis between HNRNPM and MBD2a in patients with HCC (n = 30) by IHC experiments. F, FZD3 and HNRNPM expression in protein levels in HCC tissues with strong or weak HNRNPM staining intensity. The median HNRNPM staining intensity was used as the cutoff (n = 60 HCC tissues). ∗∗∗P < .001. G-H, The correlation between the expression of HNRNPM and FZD3 (G), β-catenin (H) from TCGA datasets.